EASD 2024: Are tetra-agonists the future of metabolic diseases treatment?
According to GlobalData, combination therapy is the future of metabolic disease treatment, thus Pep2Tango’s candidate will find its space.
According to GlobalData, combination therapy is the future of metabolic disease treatment, thus Pep2Tango’s candidate will find its space.